< Terug naar vorige pagina
Onderzoeker
Kevin Punie
- Disciplines:Laboratoriumgeneeskunde, Palliatieve zorg en zorg rond het levenseinde, Regeneratieve geneeskunde, Andere basiswetenschappen, Andere gezondheidswetenschappen, Verpleegkunde, Andere paramedische wetenschappen, Andere translationele wetenschappen, Andere medische en gezondheidswetenschappen
Affiliaties
- Laboratorium Experimentele Oncologie (Afdeling)
Lid
Vanaf28 feb 2017 → Heden
Projecten
1 - 2 of 2
- Nieuwe biomerkers in de risicostratificatie, opvolging en behandeling van jonge patiënten met borstkankers en dragers van kiembaan pathogene varianten in TP53.Vanaf1 sep 2020 → 13 feb 2023Financiering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
- Terugval in borst- en gynaecologische kankers.Vanaf1 feb 2019 → 1 okt 2021Financiering: Privé-financiering van binnenlandse oorsprong - onbepaald
Publicaties
1 - 10 van 75
- Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis(2023)
Auteurs: Lieveke Ameye, Kevin Punie
Pagina's: 3075 - 3080 - Germline TP53 pathogenic variants and breast cancer: A narrative review(2023)
Auteurs: Kevin Punie
- Health-related quality of life in the phase III ASCENT trial of sacituzumab govitecan versus standard chemotherapy in metastatic triple-negative breast cancer(2023)
Auteurs: Kevin Punie
Pagina's: 23 - 33 - Management of patients with early-stage triple-negative breast cancer following pembrolizumab-based neoadjuvant therapy: What are the evidences?(2022)
Auteurs: Kevin Punie
- Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast(2022)
Auteurs: Liliana Sokol, Maxim De Schepper, Edoardo Isnaldi, Anh-Co Truong, François Richard, Ann Smeets, Ines Nevelsteen, Birgit Weynand, Christine Desmedt, Patrick Neven, et al.
- Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer(2022)
Auteurs: Kevin Punie
Pagina's: 127 - 139 - Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets(2022)
Auteurs: Huiwen Che, Liesbeth Lenaerts, Nathalie Brison, Kris Van Den Bogaert, Ruben Heremans, Agnieszka Wozniak, Christophe Dooms, Els Wauters, Sigrid Hatse, Kevin Punie, et al.
Pagina's: 1164 - 1176 - Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer(2022)
Auteurs: Kevin Punie
- Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer-phase 3 ASCENT study subanalysis(2022)
Auteurs: Kevin Punie
- Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer(2022)
Auteurs: Kevin Punie
Pagina's: 567 - 591